0000899243-20-033167.txt : 20201209 0000899243-20-033167.hdr.sgml : 20201209 20201209160510 ACCESSION NUMBER: 0000899243-20-033167 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201208 FILED AS OF DATE: 20201209 DATE AS OF CHANGE: 20201209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: D'Cruz Cony CENTRAL INDEX KEY: 0001797727 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 201377895 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-08 0 0001490978 Schrodinger, Inc. SDGR 0001797727 D'Cruz Cony C/O SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036 0 1 0 0 See Remarks Common Stock 2020-12-08 4 M 0 1114 4.34 A 1114 D Common Stock 2020-12-08 4 M 0 871 2.92 A 1985 D Common Stock 2020-12-08 4 M 0 2389 3.07 A 4374 D Common Stock 2020-12-08 4 S 0 4374 67.47 D 0 D Common Stock 2020-12-08 4 S 0 2000 67.47 D 167082 I By Cony and Pearl D'Cruz Revocable Trust dated August 20, 2019, and any amendments thereto Stock Option (right to buy) 4.34 2020-12-08 4 M 0 1114 0.00 D 2028-11-29 Common Stock 1114 18951 D Stock Option (right to buy) 2.92 2020-12-08 4 M 0 871 0.00 D 2027-06-01 Common Stock 871 2933 D Stock Option (right to buy) 3.07 2020-12-08 4 M 0 2389 0.00 D 2026-05-10 Common Stock 2389 31054 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2020. This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022. This option was granted on June 1, 2017. The shares underlying the option are scheduled to vest in equal yearly installments from January 1, 2017 through January 1, 2021. The option was granted on May 11, 2016 and is fully vested. Executive Vice President and Chief Business Officer /s/ Donald Shum, as attorney-in-fact for Cony D'Cruz 2020-12-09